Consolidated Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Operating expenses:
Depreciation	$ 0	$ 1,272	$ 0	$ 6,230
Research and development	2,192,881	2,756,081	7,232,370	7,696,983
General and administrative	1,153,032	1,566,085	4,764,617	9,135,225
Total operating expenses	3,345,913	4,323,438	11,996,987	16,838,438
Operating loss	(3,345,913)	(4,323,438)	(11,996,987)	(16,838,438)
Other income	2,405	8,080	14,056	58,851
Other financing costs	(455,549)	0	(455,549)	0
Realized and unrealized loss	(183)	(629)	(262)	(1,115)
Net loss	(3,799,240)	(4,315,987)	(12,438,742)	(16,780,702)
Deemed dividend related to warrant modification	0	0	0	(277,119)
Net loss attributable to common stockholders	$ (3,799,240)	$ (4,315,987)	$ (12,438,742)	$ (17,057,821)
Net loss per share applicable to common stockholders — basic and diluted (in dollars per share)	$ (5)	$ (61.65)	$ (23)	$ (344.92)
Weighted average number of common shares — basic and diluted (in shares)	760,502	70,013	540,910	48,651